Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Mattick, Richard P ^a   Kimber, J ^b   Breen, C ^b   Davoli, M ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE

Author keywords

Buprenorphine *therapeutic use ; Humans; Methadone *therapeutic use ; Narcotic antagonists *therapeutic use ; Narcotics *therapeutic use ; Opioid related disorders *rehabilitation ; Randomized controlled trials as topic

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; NALTREXONE; OPIATE; PLACEBO;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; OPIATE ADDICTION; OUTCOME ASSESSMENT; REVIEW; RISK FACTOR; SELF REPORT; STATISTICAL SIGNIFICANCE;

EID: 44949167587     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002207.pub3     Document Type: Review

References (55)

1. Ahmadi 2002a {published data only} Ahmadi J. A controlled trial of buprenorphine treatment for opium dependence: The first experience from Iran. Drug and Alcohol Dependence 2002;66:111-4.
2. Ahmadi 2003a {published data only} *Ahmadi J. Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients. Journal of Substance Abuse Treatment 2003;24:217-20.
3. Ahmadi 2003b {published data only} *Ahmadi J, Ahmadi K, Ohaeri J. Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: A novel study. European Journal of Clinical Investigation 2003;33:824-9.
4. Ahmadi 2004 {published data only} *Ahmadi J, Babaee-Beigi M, Alishahi M, Maany I, Hidari T. Twelve-month maintenance treatment of opium-dependent patients. Journal of Substance Abuse Treatment 2004;26:61-4.
5. Fischer 1999 {published and unpublished data} *Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stuhlinger G, et al.Buprenorphine versusmethadone maintenance for the treatment of opioid dependence. Addiction 1999;94:1337-47.
6. Fudala 2003 {published and unpublished data} *Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, et al. Office-based treatment of opiate addiciton with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine 2003;349:949-58.
7. Johnson 1992 {published and unpublished data} *Johnson R, Jaffe J, Fudala P. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992;267:2750-5. [MEDLINE: 1992251936].
8. Johnson 1995a {published and unpublished data} *Johnson RE, Eissenberg T, Stitzer M, Strain E, Liebson I, Bigelow G. A placebo controlled trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence 1995;40:17-25.
9. Johnson 2000 {published and unpublished data} *Johnson RE, Chutuape MA, Strain, EC, Walsh SL, Stitzer ML, Begelow GE. A comparison of levomethadyl acetate, buprenorphine and methadone for opioid dependence. New England Journal of Medicine 2000;343:1290-7.
10. Lott DC, Strain EC, Brooner RK, BIgelow GE, Johnson RE. HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate hydrocholoride, buprenorphine, and methadone. Journal of Substance Abuse Treatment 2006;31:187-94.
11. Kakko 2003 {published and unpublished data} *Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A ranodmised, placebo-controlled trial. Lancet 2003;361:662-8.
12. Kosten 1993 {published data only} *Kosten T, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease 1993;181:358-64. [MEDLINE: 1993274288].
13. Krook 2002 {published data only} *Krook AL, Brors O, Dahlberg J, Grouff K. Magnus P, Roysamb, et al.A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway. Addiction 2002;97:533-42.
14. Ling 1996 {published and unpublished data} *Ling W, Wesson D, Charuvastra C, Klett J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry 1996;53:401-7. [MEDLINE: 1996212784].
15. Ling 1998 {published and unpublished data} *Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Kintaudi P, et al.Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction 1998;93:475-86.
16. Lintzeris 2004 {published data only} *Lintzeris N, Ritter A, Panjari M, Clark N, Kutin J, Bammer G. Implementing buprenorphine treatment in community settings in Australia: Experiences fromthe buprenorphine implementation trial. American Journal on Addictions 2004;13:S29- S41.
17. Mattick 2003 {published data only} *Mattick RP, Ali R, White J, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: A randomised double-blind with 405 opioid-dependent patients. Addiction 2003;98:441-52.
18. Neri 2005 {published data only} *Neri S, Bruno, CM, Pulvirenti D, Malaguarnera M, Italiano C, Mauceri B, et al.Randomised clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology 2005;179:700-4.
19. Oliveto 1999 {published data only} *Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR. Desipramine in opioid-dependent cocaine abusers maintained on methadone or buprenorphine. Archives of General Psychiatry 1999;56:812-20.
20. Pani 2000 {published data only} *Pani PP, Maremmani I, Pirastu R, Tagliamonte A, Gessa GL. Buprenorphine: A controlled trial in the treatment of opioid dependence. Drug and Alcohol Dependence 2000;60:39-50.
21. Petitjean 2001 {published and unpublished data} *Petitjean S, Stohler R, Deglon JJ, Livoti S, Waldvogel D, Uehlinger C, et al.Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence 2001;62:97-104.
22. Schottenfeld 1997 {published and unpublished data} *Schottenfeld R, Pakes J, Oliveto A, Ziedonis D, Kosten T. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry 1997;54:713-20. [MEDLINE: 1997429160].
23. Schottenfeld 2005 {published data only} *Schottenfeld R, Chawarski M, Pakes J, Pantalon M, Carroll K, Kosten T. Methadone versus bupreorphine with contingency management or performance feedback for cocaine and opioid dependence. American Journal of Psychiatry 2005;162:340-9.
24. Strain 1994a {published and unpublished data} *Strain E, Stitzer M, Liebson I, Bigelow G. Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry 1994;151:1025-30. [MEDLINE: 1994279720].
25. Strain 1994b {published and unpublished data} *Strain E, Stitzer M, Liebson I, Bigelow G. Buprenorphine versus methadone in the treatment of opioid dependent cocaine users. Psychopharmocology 1994;116:401-6. [MEDLINE: 1995215552].
26. Ahmadi 2002b Ahmadi, J. Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran. Journal of Substance Abuse Treatment 2002;22:157-9.
27. Bickel 1988 Bickel W, Stitzer M, Bigelow G, Liebson I, Jasinski D, Johnson R. A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 1988;43:72-8. [MEDLINE: 1988081296].
28. Bond 2004 Bond C, Matheson C, Lawrie T, Cameron I, Robinson A, McNamee P, et al.A randomised comparison of methadone against buprenorphine in the treatment of opioid dependency: a feasability study. International Journal of Pharmacy Practice 2004;Supplement 2004:R52.
29. Bouchez 1998 Bouchez J, Beauverie P, Touzeau D. Substiitution with buprenorphine in methadone- and morphine sulfate dependent patients. European Addiction Research 1998;4 (suppl1):8-12.
30. Eder 1998 Eder H, Fischer G, Gombas W, Jagsch R, Stuehlinger G, Kasper S. Comparison of buprenorphine and methadone maintenance in opiate addicts. Eur Addict Res 1998;4:3-7.
31. Fischer 2006 Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, et al.Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction 2006;101:275-81.
32. Gerra 2004 Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bibici C, et al.Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome. Drug and Alcohol Dependence 2004;75:37-45.
33. Giacomuzzi 2003 Giacomuzzi SM, Riemer Y, Erti M, Kemmier G, Rossler H, Hinterhuber H, et al.Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health related quality of life assessment. Addiction 2003;98:693-702.
34. Harris 2005 Harris AH, Gospodarevskaya E, Ritter A. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence. Pharmacoeconomics 2005;23:77-91.
35. Johnson 1995b Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. Buprenorphine treatment of opioid dependence: Clinical trial of daily versus alternate-day dosing. Drug and Alcohol Dependence 1995;40:27-35.
36. Jones 2005a Jones HE, Johnson RE, Jasinski DR, Milio L. Randomised controlled study trasitioning opioid-dependent pregnant women from short-acting morphine to buprenophine or methadone. Drug and Alcohol Dependence 2005;78:33-8.
37. Jones 2005b Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, et al.Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: Effects on the neonatal abstinence syndrome. Drug and Alcohol Dependence 2005;79:1-10.
38. Kosten 2004 Kosten T, Falcioni J, Oliveto A, Feingold, A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. The American Journal on Addictions 2004;13:191-201.
39. Marsch 2005 Marsch LA, Bickel WK, Badger GJ, Jacobs EA. Buprenorphine treatment for opioid dependence: relative efficacy of daily, twice and thrice weekly dosing. Drug and Alcohol Dependence 2005;77:195-204.
40. Montoya 2004 Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, et al.Randomized trial of buprenorphine for treatment of current opiate and cocaine dependence. Clinical Pharmacology and Therapeutics 2004;75(1):34-48.
41. O'Connor 1998 O'Connor P, Oliveto A, Shi J, Triffleman E, Carroll K, Rounsaville B, et al.A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Medicine 1998;105(2):100-5.
42. Oliveto 1994 Oliveto A, Kosten T, Schottenfeld R, Ziedonis D, Falcioni J. Cocaine use in buprenorphine vs methadone maintained patients. Am J Addictions 1994;3(1):43-8.
43. Resnick 1992 Resnick RB, Galanter M, Pycha C, Cohen A, Grandison P, Flood N. Buprenorphine: An alternative to methadone for heroin dependence treatment. Psychopharmacology Bulletin 1992;28(1):109-13.
44. Schottenfeld 1998 Schottenfeld R, Pakes J, Kosten T. Prognostic factors in Buprenorphine versus Methadone maintained patients. J Nerv Ment Dis 1998;186(1):35-43. [MEDLINE: 1998118328].
45. Sigmon 2004 Sigmon S, Wong C, Chausmer A, Liebson I, Bigelow G. Evaluation of an injection depot formulation of buprenorphine: placebo comparison. Addiction 2004;99:1439-49.
46. Stine 1994 Stine M, Kosten T. Reduction of opiate withdrawal like symptoms by cocaine abuse during methadone and buprenorphine maintenance. Am J Drug Alcohol Abuse 1994;20(4):445-58. [MEDLINE: 1995133568].
47. Strain 1996 Strain E, Stitzer M, Liebson I, Bigelow G. Buprenorphine versus methadone in the treatment of opioid dependence: self reports, urinalysis, and addiction severity index. J Clin Psychopharmacology 1996;16(1):58-67. [MEDLINE: 1996431336].
48. Uehlinger 1998 Uehlinger C, Deglon J, Livoti S, Petitjean S, Waldvogel D, Ladewig D. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Eur Addict Res 1998;4(1):13-8.
49. Kristensen 2005 Kristensen O, Espegren O, Asland R, Jakobsen E, Lie O, Seiler S. Buprenorphine and methadone to opiate addicts - a randomized trial (English abstract only). Tidsskrift for Den Norske Laegeforening 2005;125:148-51.
50. Barnett 2001 Barnett P, Rodgers J, Bloch D. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 2001;96:683-90.
51. Fudala 1990 Fudala PJ, Jaffe JH, Dax EM, Johnson RE. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther 1990;47:525-34.
52. Jasinski 1978 Jasinski D, Pevnick J, Griffith J. Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 1978;35:501-6.
53. Mattick 1998 Mattick RP, Oliphant D, Ward J, Hall W. The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. Methadone maintenance and other opioid replacement therapies. Amsterdam: Harwood Academic Publishers, 1998:123-160.
54. West 2000 West S, O'Neal K, Graham C. A meta-analysis comparing the effectiveness of buprenorphine and methadone. Journal of Substance Abuse 2000;12:405-14.
55. Mattick review 2003 Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.